IQ-AI LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.5 GBX | 0.00% |
|
+3.45% | -68.09% |
| 05-23 | Celadon ships to US; Oxford BioDynamics-Goodbody pact | AN |
| 05-20 | IQ-AI subsidiary gets second FDA rare paediatric disease designation | AN |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Medical & Diagnostic Laboratories
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 4.23M | - | - | - | - | - | |
| 7.9B | ||||||
| 4.53B | - | - | ||||
| 2.78B | ||||||
| 2.64B | ||||||
| 1.99B |
- Stock Market
- Equities
- IQAI Stock
- Charts IQ-AI Limited
- Sector Chart